Home Tags Eli Lilly
Tag: Eli Lilly
Dispensed: Why the US healthcare system could be pushed to its limits during the coronavirus pandemic
Welcome to Dispensed. This week, a closer look at how the US healthcare system is taking on the coronavirus pandemic.
The incredible history of insulin, a lifesaving diabetes drug that was discovered almost a century ago and is now at the center of drug pricing outrag...
How a drug that was discovered 95 years ago changed the way we treat diabetes — and why it's so expensive today.
Dispensed: Change at the FDA, insurance startup financials for 2018, and the first new depression drug in 35 years
Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.
A drugmaker just released a half-price version of a life-saving diabetes medication in a bet that a lower price tag will help it escape the political ...
Eli Lilly plans to make a generic version of its life-saving diabetes medication Humalog and sell it for half the price of the branded drug.
Dispensed: Why Walgreens is partnering with Microsoft, inside the Loxo-Lilly deal, and controversial young blood startups
Welcome to Dispensed: a weekly dose of pharma, biotech, and healthcare news.
We’ll get you caught up on all the news you missed at the year’s biggest healthcare investor conference
Among the highlights: an $8 billion deal (and more to come?), a promising depression drug, and a strategy deep dive from a healthcare giant.
Welcome to Dispensed: A weekly dose of pharma, biotech, and healthcare news.
Pharma giant Eli Lilly just made an $8 billion bet on a cutting-edge scientific approach that uses DNA to treat cancer
Eli Lilly's $8 billion acquisition of the biotech company Loxo Oncology is a notably large deal, but it's open to additional ones, its CEO said.
On Thursday, pharma giant Eli Lilly and Co. announced positive results in a mid-stage trial for its experimental new diabetes drug. The company's stock was up 3% in afternoon trading.
Drugmakers are using an unusual tactic to compete in a new class of medication treating the 38 million Americans who have migraines
Until May, there weren't any FDA-approved drugs available for alleviating migraines, though other treatments — including Botox and anti-seizure medications — have been used. Pain relievers can also help treat some of the symptoms of migraines.